FIBROSARCOMA
Clinical trials for FIBROSARCOMA explained in plain language.
Never miss a new study
Get alerted when new FIBROSARCOMA trials appear
Sign up with your email to follow new studies for FIBROSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare cancers: immunotherapy trial targets tumors regardless of origin
Disease control Recruiting nowThis study tests the drug nivolumab in people with advanced rare cancers that have a specific marker (PD-L1). The goal is to see if the drug can shrink or control tumors for at least 12 months. About 28 adults who have not responded to standard treatments will take part.
Matched conditions: FIBROSARCOMA
Phase: PHASE2 • Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Disease control
Last updated May 17, 2026 06:20 UTC
-
New hope for rare sarcomas: immune drug plus chemo tested
Disease control Recruiting nowThis study tests whether adding the immunotherapy drug tislelizumab to standard chemotherapy can help shrink or control advanced soft tissue sarcomas that cannot be removed by surgery. About 45 adults aged 18-75 with certain sarcoma types will receive the combination as their fir…
Matched conditions: FIBROSARCOMA
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
3D printers may help surgeons remove tumors faster and safer
Knowledge-focused Recruiting nowThis study looks at whether using 3D printed models of a patient's bones helps surgeons plan and perform tumor removal surgery. About 150 people with bone tumors will be randomly assigned to have their surgeon use either 3D models plus regular scans, or just scans alone. The main…
Matched conditions: FIBROSARCOMA
Phase: NA • Sponsor: Ricoh USA, Inc. • Aim: Knowledge-focused
Last updated May 17, 2026 06:20 UTC